Press kit

GEROPHARM is an international rapidly growing biotechnological company with all insulin blockbusters in portfolio

• Over 20 years on the pharmaceutical market;
• Leader in the Russian insulin market*
• Own R&D center and 2 world-class manufacturing sites;
• Wide expertise in full-cycle drug development, clinical research and production of insulins bioanalogues accordance with GMP, GLP, GCP, GVP standards;
• 13 countries of export and successful international projects to localize production
• Various forms of cooperation: from export deliveries of finished products to the transfer of production technologies

* By share in monetary and physical terms (IU) in the segments of presence. Source: IQVIA, 2022, data from 06.04.23